Martin Brenner

Martin Brenner

Chief Executive Officer chez IBIO, INC.

Fortune : 37 048 $ au 31/03/2024

54 ans
Health Technology
Consumer Services

Profil

Martin B.
Brenner
's current job is Chief Executive & Scientific Officer at iBio, Inc. Formerly, Dr. Brenner worked as Senior Director & Head-BioScience at AstraZeneca PLC from 2012 to 2013.
He then served as Executive Director-Diabetes & NASH at Merck Research Laboratories Massachusetts LLC from 2013 to 2016.
Dr. Brenner was also the Head-Insulin Resistance Group at Pfizer Inc. Additionally, he held the position of Chief Scientific Officer at Recursion Pharmaceuticals, Inc. from 2017 to 2018.
From 2019 to 2020, Dr. Brenner worked as Chief Scientific Officer & Senior Vice President at Pfenex, Inc. He also served as VP & Head-Research & Early Development at Stoke Therapeutics, Inc. from 2016 to 2017.
Dr. Brenner obtained a doctorate degree from Ludwig-Maximilians-Universität München.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/11/2023 9 125 ( 0,11% ) 37 048 $ 31/03/2024

Postes actifs de Martin Brenner

SociétésPosteDébut
IBIO, INC. Chief Executive Officer 20/01/2023
Tous les postes actifs de Martin Brenner

Anciens postes connus de Martin Brenner

SociétésPosteFin
PFENEX INC. Chief Tech/Sci/R&D Officer 01/10/2020
RECURSION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/01/2018
STOKE THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2017
Director/Board Member 01/01/2016
ASTRAZENECA PLC Corporate Officer/Principal 01/01/2013
Voir l'expérience en détail de Martin Brenner

Formation de Martin Brenner

Ludwig-Maximilians-Universität München Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Martin Brenner

Relations

77

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
PFIZER, INC.

Health Technology

ASTRAZENECA PLC

Health Technology

RECURSION PHARMACEUTICALS, INC.

Health Technology

IBIO, INC.

Health Technology

STOKE THERAPEUTICS, INC.

Health Technology

Entreprise privées2

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Martin Brenner